News
China Plans to Use 13,000 satellites to Stifle Elon Musk’s Starlink
China intends to build a massive satellite network in near-Earth orbit to provide internet services to users worldwide — and to stifle Elon Musk‘s Starlink, according to a professor at the Space Engineering University in Beijing.
The project is known as “GW” and is led by associate professor Xu Can from Beijing’s People’s Liberation Army’s (PLA) Space Engineering University. However, it is unclear what these letters stand for.
According to Professor Xu and his colleagues in a paper about Anti-Starlink measures published in the Chinese journal Command Control and Simulation on February 15, the GW constellation will include 12,992 satellites owned by the newly established China Satellite Network Group.
The launch date for these satellites is unknown, but their number would allegedly rival SpaceX’s planned network of over 12,000 satellites by 2027. The GW satellite constellation is expected to be deployed quickly “before the completion of Starlink,” according to Xu’s team.
This would “ensure that our country has a place in low orbit and prevent the Starlink constellation from pre-empting low-orbit resources excessively,” they wrote.
The researchers said the Chinese satellites could also be placed in “orbits where the Starlink constellation has not yet reached, ” adding that they would “gain opportunities and advantages at other orbital altitudes and even suppress them Starlink”.
The Chinese satellites could be outfitted with an anti-Starlink payload to perform a variety of missions, including “close-range, long-term surveillance of Starlink satellites,” according to the report.
According to a recent China National Space Administration study, competing communication satellite networks could harm each other.
According to SpaceX, the Starlink network, which currently has over 3,000 satellites in orbit, is expected to grow to more than 40,000 satellites.
However, Xu’s team says China’s space surveillance and defense capabilities couldn’t handle such many satellites.
According to the paper, the Starlink satellites can receive data from the US Department of Defense to plan or coordinate their positions, and they are outfitted with surveillance sensors to monitor the space environment.
“The Starlink satellites may actively hit and destroy nearby targets in space,” the researchers said.
According to the report, China intends to build more powerful radar systems powered by new technology to identify and track Starlink satellites.
According to the researchers, the radar and other detection measures would be used to update a “Starlink catalog” that would eventually contain detailed data on every satellite.
Xu’s team said the government of China could also cooperate with other governments to form an anti-Starlink coalition and “demand that SpaceX publishes the precise orbiting data of Starlink satellites”.
They said new weapons, such as lasers and high-powered microwaves, would be developed and used to destroy Starlink satellites that pass over China or other sensitive areas.
The Ukrainian military has successfully used Starlink services against Russian forces. Since the war began, Chinese military researchers have repeatedly urged the development of capabilities capable of destroying Starlink if necessary.
On February 13, SpaceX founder Elon Musk tweeted that the company would restrict the military use of Starlink in the Ukraine war because “we will not enable escalation of a conflict that may lead to WW3”.
On February 18, US Secretary of State Antony Blinken stated that the US government had discussed the use of Starlink satellite internet in Ukraine with Musk, but he did not elaborate.
News
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
PARIS — Katie Ledecky is looking for clean Olympic races. On Wednesday, Hope had pretty much reached her limit.
The American swimmer hopes to add to her six gold medals as she competes in the 400, 800, and 1,500 meters at the Paris Games. Her program starts with the heavy 400 on Saturday, featuring Ariarne Titmus and Summer McIntosh.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
The 27-year-old Katie is competing in her fourth Summer Olympics, but the first since a doping scandal involving almost two dozen Chinese swimmers who tested positive for a banned chemical before the Tokyo Games — yet were permitted to compete with no consequences. The controversy has raised serious worries regarding the effectiveness of anti-doping initiatives.
Katie Ledecky | Vogue Image
“I hope everyone here is going to be competing clean this week,” Ledecky claimed. “But what truly counts is, were they training cleanly? Hopefully this has been the case. Hopefully, there has been worldwide testing.”
The International Olympic Committee has expressed concern over the ongoing US investigation into possible doping by Chinese swimmers. While awarding the 2034 Winter Olympics to Salt Lake City on Wednesday, the IOC urged Utah officials to do whatever they could to stop the FBI investigation.
“I think everyone’s heard what the athletes think,” Katie added. “They seek transparency. They want more answers to the remaining questions. At this point, we are here to race. We are going to race whoever is in the lane next to us.
“We are not paid to conduct the tests, so we trust those who follow their regulations. That applies both today and in the future.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
SOURCE | AP
News
London Heatwave Alert: High Temperatures Set to Soar to 29C Next Week
As the summer holidays begin, London may experience an official heatwave with temperatures reaching up to 29 degrees Celsius.
The Met Office predicts a long period of sunny and dry weather for London after a soggy spring and summer.
After a cloudy day on Saturday, temperatures are expected to reach 27C on Sunday, with lots of sunlight.
On Monday and Tuesday, temperatures are forecast to peak at 29 degrees Celsius. Monday is forecast to offer more sunlight, while Tuesday may see some gloomy weather.
Temperatures are expected to remain in the high 20s next week, with lows of approximately 18C.
According to the Met Office, a heatwave is “an extended period of hot weather relative to the expected conditions of the area at that time of year, which may be accompanied by high humidity.”
In the United Kingdom, a heatwave is proclaimed when daily temperatures meet or surpass a certain level for at least three consecutive days.
In London, the heatwave threshold is 28 degrees Celsius.
The Met Office reported that the UK is experiencing hotter and wetter weather on average due to climate change.
The UK experienced its warmest May and April on record this year, despite damp and dismal conditions in many areas.
According to the Met Office’s State Of The UK Climate 2023 report published on Thursday, the UK experienced historic levels of extreme weather last year.
In the United Kingdom, 2023 was the second warmest year on record, bringing storms, flooding, strong heatwaves, and rising sea levels; only 2022 was warmer.
It was 0.8°C higher than the average from 1991 to 2020, and 1.66°C higher than the 1961 to 1990 average.
However, 2023 will be a “cool year” in comparison to 2100, based on the planet’s warming trajectory.
The government’s plan to adapt to the hazards presented by climate change is currently being challenged in the High Court by campaigners who allege the Tory administration’s July 2023 National Adaptation Programme (NAP) fails to adequately address 61 concerns.
Source: The Standard
News
Novo Nordisk’s Wegovy is a Heart-Risk-Reducing Product.
(VOR News) – The European Union’s medical regulator has granted approval to Wegovy, a blockbuster weight loss treatment manufactured by Novo Nordisk, in order to expand its application to include the reduction of major heart events in overweight or obese adults.
In order to expand the scope of the medication’s applicability, this authorisation was granted. The purpose of obtaining this approval was to broaden the medicine’s application.
The Danish pharmaceutical company announced on Thursday that the European Medical Agency has formulated a “positive opinion” regarding the label’s expansion.
The agency made this determination after conducting a comprehensive examination of the results of a SELECT study that was subjected to rigorous monitoring. Other applications of the substance are facilitated by this conclusion.
The SELECT experiment, which was financed by Novo Nordisk and published in August 2023.
Wegovy and Ozempic contain semaglutide as the active ingredient.
Reduced the risk of major cardiovascular events by twenty percent when compared to a placebo. The researchers arrived at this conclusion. This realisation was the outcome of the researchers’ investigation.
The notion that the European Medicines Agency label for Wegovy should be amended is a significant step forward for patients who are coping with cardiovascular disease and obesity, according to Martin Holst Lange, executive vice president and director of development at Novo Nordisk.
The company’s statement, which was disclosed, indicated that the recommendation to update the label is a substantial advancement.
It is evident that Wegovy has the potential to save lives by reducing the likelihood of significant adverse cardiovascular events, as evidenced by the findings of the SELECT research. An additional benefit of participating in this exercise is that it helps individuals effectively manage their weight, which is a benefit in and of itself.
The company also stated that the label update incorporates data from the SELECT trial, which showed a 15% reduction in the risk of death from cardiovascular causes and a 19% reduction in the risk of death from any cause when compared to situations in which a placebo was used in conjunction with the product.
The SELECT trial was conducted in the United States, according to the company. Furthermore, the organisation disclosed that the SELECT investigation was conducted in the United States of America.
It is anticipated that the label amendment will be implemented within the next month, as per the statement issued by Novo Nordisk.
Wegovy has also been approved for use in the United States.
Similarly, the UK medical regulator has taken similar actions. The United Kingdom on Tuesday granted its clearance for the use of Wegovy to reduce the risk of significant cardiac difficulties or strokes in adults who are overweight or obese, such as heart attacks or strokes.
The Food and Drug Administration of the United States of America granted sanction for the medicine to be used in specific applications during the month of March.
This resulted in a rise in the number of distinct applications for the highly popular treatment, which coincides with the sector’s increasing level of competition.
On Thursday, Roche, a global pharmaceutical company with its headquarters in Switzerland, announced that its Wegovy competitor weight reduction tablets will be incorporated into a collection of pharmaceuticals designed to mitigate the adverse effects of obesity.
The pharmaceutical collection will encompass a diverse selection of weight loss medications.
The company’s Chief Executive Officer, Thomas Schinecker, conveyed his satisfaction with the exceptional early-stage trial results of the two potential weight-reduction pharmaceuticals that the company is currently developing. In addition, he asserted that these medications demonstrated the “best in disease potential.”
In making this assertion, Schinecker was alluding to the fact that the medications exhibited the “best in disease potential.” He also stated that they will be a part of a more comprehensive portfolio that is intended to set the Swiss company apart from its competitors in the growing obesity therapy market.
This adds insult to injury. This strategy will be implemented in order to distinguish the Swiss company from other businesses in the market.
SOURCE: CNBC
SEE ALSO:
A Strong U.S. GDP Report Boosts Oil, but Asia’s Economic Woes Limit Gains.
Surge in Covid Cases in Greece: Tourists Issued FLiRT Variant Warning
Business Owners Blame the Government’s Economic Incompetence for Rising Inflation.
-
World2 weeks ago
Former President Trump Survives Being Shot at Pennsylvania Rally
-
Tech4 weeks ago
Huawei Launches 5G-A Pioneers Program at MWC Shanghai 2024: Paving the Way for a Connected Future
-
Tech4 weeks ago
ChatGPT Answers Undiscovered Questions and Outperforms Students.
-
Sports4 weeks ago
NBA Draft: Kyle Filipowski Withdraws Unexpectedly From The First Round
-
News4 weeks ago
US Supreme Court Rejects Drug Deal that Protects the Sackler Family
-
Health4 weeks ago
US Health Agency Issues Dengue Virus Infection Warning